ECB-ART-46823
Clinics (Sao Paulo)
2018 Dec 10;73suppl 1:e814s. doi: 10.6061/clinics/2018/e814s.
Show Gene links
Show Anatomy links
Autophagy and intermittent fasting: the connection for cancer therapy?
Antunes F
,
Erustes AG
,
Costa AJ
,
Nascimento AC
,
Bincoletto C
,
Ureshino RP
,
Pereira GJS
,
Smaili SS
.
Abstract
Cancer is a leading cause of death worldwide, and its incidence is continually increasing. Although anticancer therapy has improved significantly, it still has limited efficacy for tumor eradication and is highly toxic to healthy cells. Thus, novel therapeutic strategies to improve chemotherapy, radiotherapy and targeted therapy are an important goal in cancer research. Macroautophagy (herein referred to as autophagy) is a conserved lysosomal degradation pathway for the intracellular recycling of macromolecules and clearance of damaged organelles and misfolded proteins to ensure cellular homeostasis. Dysfunctional autophagy contributes to many diseases, including cancer. Autophagy can suppress or promote tumors depending on the developmental stage and tumor type, and modulating autophagy for cancer treatment is an interesting therapeutic approach currently under intense investigation. Nutritional restriction is a promising protocol to modulate autophagy and enhance the efficacy of anticancer therapies while protecting normal cells. Here, the description and role of autophagy in tumorigenesis will be summarized. Moreover, the possibility of using fasting as an adjuvant therapy for cancer treatment, as well as the molecular mechanisms underlying this approach, will be presented.
PubMed ID: 30540126
PMC ID: PMC6257056
Article link: Clinics (Sao Paulo)
Species referenced: Echinodermata
Genes referenced: LOC100888004 LOC115919910 LOC115925116 LOC582192 ros1
Article Images: [+] show captions
|
|
Figure 1. Presumable molecular mechanisms induced by fasting and anticancer treatment to promote intracellular changes and autophagy induction in tumor cells. I) Fasting may oppose the Warburg effect (glucose breakdown by glycolysis even in the presence of oxygen), favoring oxidative phosphorylation in tumor cells and resulting in increased ROS production and reduced levels of lactate and possibly ATP. The increase in the ADP/ATP ratio can activate the AMPK pathway, leading to autophagy induction. Moreover, the sustained stressful environment can result in cell death induction. II) Several tumors harbor mutations that favor MAPK pathway hyperactivation, which enables tumor cell growth, survival and proliferation. Therapies targeting this pathway, as well as fasting, may result in the downregulation of this pathway alongside a reduction in AKT and mTOR activation, resulting in autophagy induction and cell death. III) Furthermore, fasting potentiates the detrimental effects of chemotherapy, such as DNA damage, thus activating the cell death machinery, deregulating pro- and antiapoptotic proteins, and inducing mitochondrial alterations and caspase activation, which in turn culminates in apoptosis. |
References [+] :
Amaravadi,
Recent insights into the function of autophagy in cancer.
2016, Pubmed
Amaravadi, Recent insights into the function of autophagy in cancer. 2016, Pubmed
Antonioli, Emerging Mechanisms in Initiating and Terminating Autophagy. 2017, Pubmed
Antunes, Fasting boosts sensitivity of human skin melanoma to cisplatin-induced cell death. 2017, Pubmed
Bianchi, Fasting induces anti-Warburg effect that increases respiration but reduces ATP-synthesis to promote apoptosis in colon cancer models. 2015, Pubmed
Bincoletto, Interplay between apoptosis and autophagy, a challenging puzzle: new perspectives on antitumor chemotherapies. 2013, Pubmed
Bravo-San Pedro, Autophagy and Mitophagy in Cardiovascular Disease. 2017, Pubmed
Cadwell, Crosstalk between autophagy and inflammatory signalling pathways: balancing defence and homeostasis. 2016, Pubmed
Caffa, Fasting potentiates the anticancer activity of tyrosine kinase inhibitors by strengthening MAPK signaling inhibition. 2015, Pubmed
Chen, Autophagy as a therapeutic target in cancer. 2011, Pubmed
Chen, Combining radiation with autophagy inhibition enhances suppression of tumor growth and angiogenesis in esophageal cancer. 2015, Pubmed
Chiarini, Current treatment strategies for inhibiting mTOR in cancer. 2015, Pubmed
Corazzari, Oncogenic BRAF induces chronic ER stress condition resulting in increased basal autophagy and apoptotic resistance of cutaneous melanoma. 2015, Pubmed
D'Aronzo, Fasting cycles potentiate the efficacy of gemcitabine treatment in in vitro and in vivo pancreatic cancer models. 2015, Pubmed
Degenhardt, Autophagy promotes tumor cell survival and restricts necrosis, inflammation, and tumorigenesis. 2006, Pubmed
Di Biase, Fasting regulates EGR1 and protects from glucose- and dexamethasone-dependent sensitization to chemotherapy. 2017, Pubmed
Dorff, Safety and feasibility of fasting in combination with platinum-based chemotherapy. 2016, Pubmed
Dwarakanath, Targeting glucose metabolism with 2-deoxy-D-glucose for improving cancer therapy. 2009, Pubmed
Fulda, Autophagy in Cancer Therapy. 2017, Pubmed
Galluzzi, Pharmacological modulation of autophagy: therapeutic potential and persisting obstacles. 2017, Pubmed
Galluzzi, Activating autophagy to potentiate immunogenic chemotherapy and radiation therapy. 2017, Pubmed
Galluzzi, Autophagy in malignant transformation and cancer progression. 2015, Pubmed
Galluzzi, Molecular definitions of autophagy and related processes. 2017, Pubmed
Gewirtz, The Challenge of Developing Autophagy Inhibition as a Therapeutic Strategy. 2016, Pubmed
Gigli, The biphosphinic paladacycle complex induces melanoma cell death through lysosomal-mitochondrial axis modulation and impaired autophagy. 2016, Pubmed
Grasso, Autophagy regulates Selumetinib (AZD6244) induced-apoptosis in colorectal cancer cells. 2016, Pubmed
Guo, Activated Ras requires autophagy to maintain oxidative metabolism and tumorigenesis. 2011, Pubmed
Ha, Novel pharmacological modulators of autophagy: an updated patent review (2012-2015). 2016, Pubmed
He, The Beclin 1 interactome. 2010, Pubmed
Ichimura, A ubiquitin-like system mediates protein lipidation. 2000, Pubmed
Kaur, Autophagy at the crossroads of catabolism and anabolism. 2015, Pubmed
Kaushik, Chaperone-mediated autophagy: a unique way to enter the lysosome world. 2012, Pubmed
Kimmelman, Autophagy and Tumor Metabolism. 2017, Pubmed
Klionsky, A unified nomenclature for yeast autophagy-related genes. 2003, Pubmed
Kopeina, Caloric restriction - A promising anti-cancer approach: From molecular mechanisms to clinical trials. 2017, Pubmed
Kroemer, Autophagy and the integrated stress response. 2010, Pubmed
Laddha, Mutational landscape of the essential autophagy gene BECN1 in human cancers. 2014, Pubmed
Lavallard, Autophagy, signaling and obesity. 2012, Pubmed
Lebovitz, Cross-cancer profiling of molecular alterations within the human autophagy interaction network. 2015, Pubmed
Lee, Fasting cycles retard growth of tumors and sensitize a range of cancer cell types to chemotherapy. 2012, Pubmed
Lee, Reduced levels of IGF-I mediate differential protection of normal and cancer cells in response to fasting and improve chemotherapeutic index. 2010, Pubmed
Levine, Development by self-digestion: molecular mechanisms and biological functions of autophagy. 2004, Pubmed
Levy, Targeting autophagy in cancer. 2017, Pubmed
Liang, Induction of autophagy and inhibition of tumorigenesis by beclin 1. 1999, Pubmed
Liang, Autophagy inhibition plays the synergetic killing roles with radiation in the multi-drug resistant SKVCR ovarian cancer cells. 2012, Pubmed
Lin, Structure and function of the ULK1 complex in autophagy. 2016, Pubmed
Liu, Metformin partially reverses the carboplatin-resistance in NSCLC by inhibiting glucose metabolism. 2017, Pubmed
Liu, Inhibition of Autophagy by Chloroquine Enhances the Antitumor Efficacy of Sorafenib in Glioblastoma. 2016, Pubmed
Lo Re, Fasting inhibits hepatic stellate cells activation and potentiates anti-cancer activity of Sorafenib in hepatocellular cancer cells. 2018, Pubmed
Lock, Autophagy-dependent production of secreted factors facilitates oncogenic RAS-driven invasion. 2014, Pubmed
Lock, Autophagy facilitates glycolysis during Ras-mediated oncogenic transformation. 2011, Pubmed
Longo, Fasting: molecular mechanisms and clinical applications. 2014, Pubmed
Madeo, Caloric restriction mimetics: towards a molecular definition. 2014, Pubmed
Mathew, Autophagy, stress, and cancer metabolism: what doesn't kill you makes you stronger. 2011, Pubmed
Mathew, Autophagy suppresses tumor progression by limiting chromosomal instability. 2007, Pubmed
Mattson, Impact of intermittent fasting on health and disease processes. 2017, Pubmed
Menzies, Autophagy and Neurodegeneration: Pathogenic Mechanisms and Therapeutic Opportunities. 2017, Pubmed
Michalsen, Incorporation of fasting therapy in an integrative medicine ward: evaluation of outcome, safety, and effects on lifestyle adherence in a large prospective cohort study. 2005, Pubmed
Mijaljica, Microautophagy in mammalian cells: revisiting a 40-year-old conundrum. 2011, Pubmed
Miranda, Phase 2 Trial of Metformin Combined With 5-Fluorouracil in Patients With Refractory Metastatic Colorectal Cancer. 2016, Pubmed
Mizushima, A protein conjugation system essential for autophagy. 1998, Pubmed
Mizushima, Autophagy: renovation of cells and tissues. 2011, Pubmed
Mizushima, The role of Atg proteins in autophagosome formation. 2011, Pubmed
Mizushima, In vivo analysis of autophagy in response to nutrient starvation using transgenic mice expressing a fluorescent autophagosome marker. 2004, Pubmed
Mou, Curcumin inhibits cell proliferation and promotes apoptosis of laryngeal cancer cells through Bcl-2 and PI3K/Akt, and by upregulating miR-15a. 2017, Pubmed
O'Flanagan, When less may be more: calorie restriction and response to cancer therapy. 2017, Pubmed
Palmeira dos Santos, Comparative study of autophagy inhibition by 3MA and CQ on Cytarabine‑induced death of leukaemia cells. 2014, Pubmed
Pankiv, p62/SQSTM1 binds directly to Atg8/LC3 to facilitate degradation of ubiquitinated protein aggregates by autophagy. 2007, Pubmed
Papandreou, Hypoxia signals autophagy in tumor cells via AMPK activity, independent of HIF-1, BNIP3, and BNIP3L. 2008, Pubmed
Pietrocola, Caloric Restriction Mimetics Enhance Anticancer Immunosurveillance. 2016, Pubmed
Puissant, When autophagy meets cancer through p62/SQSTM1. 2012, Pubmed
Qu, Promotion of tumorigenesis by heterozygous disruption of the beclin 1 autophagy gene. 2003, Pubmed
Raffaghello, Fasting and differential chemotherapy protection in patients. 2010, Pubmed
Raffaghello, Starvation-dependent differential stress resistance protects normal but not cancer cells against high-dose chemotherapy. 2008, Pubmed
Rangwala, Phase I trial of hydroxychloroquine with dose-intense temozolomide in patients with advanced solid tumors and melanoma. 2014, Pubmed
Safdie, Fasting enhances the response of glioma to chemo- and radiotherapy. 2012, Pubmed
Safdie, Fasting and cancer treatment in humans: A case series report. 2009, Pubmed
Saleh, Caloric restriction augments radiation efficacy in breast cancer. 2013, Pubmed
Saxton, mTOR Signaling in Growth, Metabolism, and Disease. 2017, Pubmed
Settembre, TFEB controls cellular lipid metabolism through a starvation-induced autoregulatory loop. 2013, Pubmed
Sharifi, Autophagy Promotes Focal Adhesion Disassembly and Cell Motility of Metastatic Tumor Cells through the Direct Interaction of Paxillin with LC3. 2016, Pubmed
Simone, Selectively starving cancer cells through dietary manipulation: methods and clinical implications. 2013, Pubmed
Speakman, Caloric restriction. 2011, Pubmed
Sun, Fasting inhibits colorectal cancer growth by reducing M2 polarization of tumor-associated macrophages. 2017, Pubmed
Takamura, Autophagy-deficient mice develop multiple liver tumors. 2011, Pubmed
Takeshige, Autophagy in yeast demonstrated with proteinase-deficient mutants and conditions for its induction. 1992, Pubmed
Tasdemir, Regulation of autophagy by cytoplasmic p53. 2008, Pubmed
Tinkum, Fasting protects mice from lethal DNA damage by promoting small intestinal epithelial stem cell survival. 2015, Pubmed
Tsukada, Isolation and characterization of autophagy-defective mutants of Saccharomyces cerevisiae. 1993, Pubmed
Vakifahmetoglu-Norberg, Pharmacologic agents targeting autophagy. 2015, Pubmed
Wang, Spermidine/spermine N1-acetyltransferase regulates cell growth and metastasis via AKT/β-catenin signaling pathways in hepatocellular and colorectal carcinoma cells. 2017, Pubmed
White, The role for autophagy in cancer. 2015, Pubmed
White, Deconvoluting the context-dependent role for autophagy in cancer. 2012, Pubmed
Xu, Resveratrol reverses Doxorubicin resistance by inhibiting epithelial-mesenchymal transition (EMT) through modulating PTEN/Akt signaling pathway in gastric cancer. 2017, Pubmed
Yang, Mammalian autophagy: core molecular machinery and signaling regulation. 2010, Pubmed
Yue, Beclin 1, an autophagy gene essential for early embryonic development, is a haploinsufficient tumor suppressor. 2003, Pubmed
de Groot, The effects of short-term fasting on tolerance to (neo) adjuvant chemotherapy in HER2-negative breast cancer patients: a randomized pilot study. 2015, Pubmed